BP 606 1.25 (Glyburide 1.25 mg)
Pill imprint BP 606 1.25 has been identified as Glyburide 1.25 mg.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- BP 606 1.25
- Strength:
- 1.25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- TruPharma, LLC
More about glyburide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 5 Reviews – Add your own review/rating
- Drug class: sulfonylureas
Consumer resources
Other brands: DiaBeta, Micronase, Glynase, Glycron, Glynase PresTab
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
